K-ras G12C inhibitor For more information, please see the following patent. Heterocyclic compounds as covalent inhibitors of G12C mutant K-Ras protein useful for treating cancers.K-Ras G12C-IN-3 is a novel and irreversible inhibitor of mutant K-ras G12C.

1629268-19-4

C21H19Cl3N2O3

453.75

K-Ras G12C-IN-3

DMSO:30 mg/mL (66.12 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years